Cue Biopharma, Inc. Made Big Gain
Fri, May 01, 2026 at 07:37 PM
Cue Biopharma, Inc. (CUE:NASDAQ) soared at $30.42, a gain of 106.4%. On Fri, May 01, 2026, CUE:NASDAQ hit a New 2-Week High of $30.42. The stock got featured on our News Catalysts scanner on Fri, May 01, 2026 at 02:11 AM in the 'PRIVATE PLACEMENT' category. From Fri, Apr 17, 2026, the stock recorded 60.00% Up Days and 54.55% Green Days
About Cue Biopharma, Inc. (CUE:NASDAQ)
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Top 10 Gainers:
- AIOS Tech Inc Cl A (AIOS:NASDAQ), 140.17%
- Cue Biopharma, Inc. (CUE:NASDAQ), 106.38%
- Esperion Therapeutics, Inc. (ESPR:NASDAQ), 55.5%
- Streamex Corp. (STEX:NASDAQ), 54.21%
- Ten-League International Holdings Limited (TLIH:NASDAQ), 50.8%
- Urban One, Inc. (UONE:NASDAQ), 39.24%
- DMC Global Inc. (BOOM:NASDAQ), 36.08%
- Pershing Square Inc. (PS:NYSE), 35.68%
- Atomera Incorporated (ATOM:NASDAQ), 35.57%
- Direct Digital Holdings, Inc. (DRCT:NASDAQ), 34.34%